The temporal relationship between the development of symptoms about three days after gabapentin discontinuation and the absence of any improvements during the administration of benzodiazepines for ...

Gabapentin is not likely to cause addiction, but it may lead to dependence or misuse under certain conditions. As such, doctors prescribe gabapentin carefully to avoid withdrawal symptoms and ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Since then, she’s been experiencing continued neuropathy that involves itchiness, a sense of desperation, and some pain.

MIRA Pharmaceuticals (MIRA, Financial) shares soared by 40% after the company achieved a significant breakthrough in ...

Among patients on dialysis taking gabapentin, the major adverse events rate (per 100 person-years) ranged from 9.3 for any fracture to 37.8 for altered mental status. Gabapentin treatment ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

MIRA Pharmaceuticals (MIRA) announces new preclinical findings showing that Ketamir-2, a novel oral ketamine analog, achieves 60% greater ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to announce that its novel oral ketamine analog, Ketamir-2, has shown greater pain ...

Non-Habit Forming: Unlike Pregabalin, Ketamir-2 carries no known risk of dependence, making it safer for long-term use. Fewer Cognitive Side Effects: With the potential to avoid sedation and ...